New Delhi: The Covid-19 pandemic brought the world to a standstill, exposing gaps in healthcare infrastructure and driving the urgent need for advanced diagnostic and treatment solutions. In a study conducted by the Patanjali Research Institute, nanotechnology has emerged as a promising innovation in the identification and treatment of the Covid-19 virus.
According to the research, diagnostic techniques based on nanotechnology can play a crucial role in early detection of the virus. Nanoparticles — tiny structures engineered at the molecular and atomic level — have shown the ability to specifically target certain cells or tissues, enhancing both the accuracy and efficiency of virus detection.
Nanoparticles can deliver vaccines directly to targeted cells
The study revealed that nanotechnology-based virus-like particle vaccines could prove highly effective against Covid-19. These nanoparticles are capable of delivering vaccines directly to targeted cells, increasing the effectiveness of the immune response while also ensuring safety. Researchers pointed out that such technologies could revolutionise not only Covid-19 treatment but also the prevention and management of a range of viral infections.
“Nanotechnology enables the design and production of structures, devices, and systems by manipulating atoms and molecules,” explained scientists at Patanjali Research Institute. “Following the devastation of the coronavirus pandemic, the need for new methods became more urgent than ever, and nanotechnology has shown remarkable promise.”
Rapid and highly sensitive detection of viruses
Biosensors developed using nanotechnology offer rapid and highly sensitive detection of viruses, including SARS-CoV-2. These biosensors provide accurate and early diagnoses, which are critical in containing the spread of infectious diseases.
Pre-clinical trials have further strengthened the potential of nanotechnology, with nanoparticle-based devices demonstrating effectiveness against respiratory viruses, herpes viruses, human papillomavirus (HPV), and HIV. Polymeric, inorganic, and organic nanoparticles — sized at the nanometre scale (10−9 metres) — act as biological agents that could be pivotal in accurate disease diagnosis and innovative treatments.
